Demonstration of beta 1-adrenergic receptors in human placenta by (-)[125I]iodocyanopindolol binding. 1989

A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri

The highly specific beta-adrenergic radioligand (-)[125I]iodocyanopindolol (ICYP) was used to characterize the beta-adrenergic receptor subtype present in human placenta. Binding of ICYP to membranes from human placenta was saturable with time and ligand concentration, of high affinity, and demonstrated appropriate stereoselectivity and agonist rank order of potency for binding to a beta-adrenergic receptor. From saturation binding curves, the KD and Bmax values for ICYP binding were 233 +/- 51 pM and 690 +/- 139 fmol/mg of proteins, respectively. Analysis of inhibition of ICYP binding by beta 1- and beta 2-selective adrenergic antagonists via Hofstee analysis resulted in linear plots, indicating the existence of a homogeneous population of beta-adrenergic receptors. From the resulting KI-values for the beta 1-selective drugs practolol (4.0 +/- 0.9 microM) and metoprolol (0.19 +/- 0.07 microM) and for the beta 2-selective drug ICI 118,551 (0.30 +/- 0.06 microM) it is concluded that the beta-adrenergic receptor in human placenta is of the beta 1-subtype. This is further supported by the fact that (-)-noradrenaline and (-)-adrenaline were equipotent in inhibiting ICYP binding.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D020120 Iodocyanopindolol A highly selective and specific beta antagonist that is used to characterize beta-adrenoceptors. ICYP,I-Cyanopindolol,I Cyanopindolol

Related Publications

A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
January 1987, Gynecologic and obstetric investigation,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
February 1990, Japanese journal of pharmacology,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
February 1984, The American journal of physiology,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
May 1982, Biochemical pharmacology,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
July 1988, The Journal of comparative neurology,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
August 1987, Chemical & pharmaceutical bulletin,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
December 1983, Circulation research,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
September 1989, Journal of pharmacobio-dynamics,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
July 1987, Chemical & pharmaceutical bulletin,
A Paci, and F Cocci, and F Piras, and H P Niedermeyer, and E Matteucci, and C Vitali, and G Ciarimboli, and S Bombardieri
April 1982, Biochimica et biophysica acta,
Copied contents to your clipboard!